| Literature DB >> 32394777 |
Sebastian Koch1, Eduard Tiozzo2, Marialaura Simonetto1, David Loewenstein2, Clinton B Wright3, Chuanhui Dong1, Antonio Bustillo1, Miguel Perez-Pinzon1, Kunjan R Dave1, Carolina M Gutierrez1, John E Lewis2, Marti Flothmann1,4, M Carolina Mendoza-Puccini3, Barbara Junco1, Zuzel Rodriguez1, Joyce Gomes-Osman2,4, Tatjana Rundek1,4, Ralph L Sacco1,4.
Abstract
Background Physical exercise and cognitive training have been recommended to improve cognitive outcomes poststroke, but a multifaceted strategy including aerobic, resistance, and cognitive training to facilitate poststroke recovery has not been investigated. We aimed to assess the feasibility, adherence, and safety of a combined aerobic, resistance, and cognitive training intervention (CARET+CTI) after stroke. Methods and Results We prospectively randomized patients presenting with recent stroke to a comparison of a supervised 12-week CARET+CTI program and a control group receiving sham CARET+CTI. Participants were scheduled for 3 weekly CARET and CTI sessions. All participants underwent pre- and postintervention assessments of strength, endurance, and cognition. The primary outcomes were feasibility and adherence, defined as the ratio of scheduled and observed visits, and safety. We enrolled 131 participants, of whom 37 withdrew from the study. There were 17 (20%) withdrawals in the CARET+CTI and 20 (44%) in the control group. The observed-over-expected visit ratio was significantly higher in the intervention than in the control group (0.74±0.30 versus 0.54±0.38; P=0.003). A total of 99 adverse events were reported by 59 participants, none of which were serious and related to the intervention. Greater gains in physical, cognitive, and mood outcomes were found in the CARET+CTI group than in the control group, but were not statistically significant after adjustments. Conclusions A CARET+CTI intervention, after stroke, is safe, feasible, and has satisfactory participant adherence over 12 weeks. REGISTRATION URL: https://www.clinicaltrials.gov. Unique identifier: NCT02272426.Entities:
Keywords: cognitive training; exercise; randomized clinical trial; stroke recovery
Mesh:
Year: 2020 PMID: 32394777 PMCID: PMC7660866 DOI: 10.1161/JAHA.119.015377
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Baseline Characteristics of Intervention and Control Groups
| Tot (n=131) |
| ||
|---|---|---|---|
| Intervention (n=86) | Control (n=45) | ||
| Sociodemographics | |||
| Age, y, mean (SD) | 59 (11) | 58 (12) | 0.55 |
| Women, n (%) | 26 (30) | 24 (53) | 0.01 |
| Race, n (%) | |||
| White | 51 (59) | 20 (44) | 0.17 |
| Black | 30 (35) | 20 (44) | |
| Other | 5 (6) | 5 (10) | |
| Ethnicity, n (%) | |||
| Hispanic | 47 (55) | 21 (47) | 0.38 |
| Non‐Hispanic | 38 (44) | 23 (51) | |
| Unknown | 1 (1) | 1 (2) | |
| Years of education, mean (SD) | 13 (4) | 13 (3) | 0.62 |
| Clinical risk factors | |||
| Hypertension, n (%) | 72 (84) | 36 (80) | 0.37 |
| Dyslipidemia, n (%) | 60 (70) | 30 (67) | 0.92 |
| Diabetes mellitus, n (%) | 23 (27) | 20 (44) | 0.04 |
| Atrial fibrillation, n (%) | 4 (5) | 3 (7) | 0.53 |
| BMI, mean (SD) | 29 (4) | 31 (5) | 0.01 |
| CAD, n (%) | 6 (7) | 4 (9) | 0.68 |
| Stroke characteristics | |||
| Days from stroke to enrollment (median) | 154 | 148 | 0.60 |
| Ischemic, n (%) | 70 (81) | 38 (84) | 0.47 |
| Ischemic stroke subtype | |||
| Cardioembolism, n (%) | 9 (13) | 6 (16) | 0.11 |
| Large vessel disease, n (%) | 30 (43) | 9 (24) | |
| Small vessel disease, n (%) | 22 (31) | 20 (53) | |
| Other cause, n (%) | 9 (13) | 3 (8) | |
| NIHSS, median (Q1, Q3) | 3 (1;4) | 2 (1;4) | 0.92 |
| mRS, median (Q1, Q3) | 2 (2;3) | 2 (2;3) | 0.71 |
BMI indicates body mass index; CAD, coronary artery disease; NIHSS, National Institute of Health Stroke Scale; and mRS, modified ranking scale.
Figure 1A, Kaplan‐Meier curves demonstrating earlier and more frequent withdrawals in the control group and (B) reasons for withdrawing.
Cognitive Assessments, Mood, and Quality of Life
| Intervention Arm (Total n=131) | Baseline | 3‐Month Follow‐up | Paired | Averaged Intraindividual Change |
|
|---|---|---|---|---|---|
| MoCA score, mean (SD) | |||||
| Intervention (n=86) | 19.5 (5.6) | 20.7 (5.6) | 0.02 | 0.7 (2.5) | 0.13 |
| Control (n=45) | 20.7 (5.7) | 21.1 (6.0) | 0.67 | 0.2 (2.9) | |
| CES‐D score, mean (SD) | |||||
| Intervention (n=86) | 16 (12) | 12 (10) | 0.01 | −3 (10) | 0.70 |
| Control (n=45) | 18 (12) | 14 (12) | 0.01 | −5 (10) | |
| SIS‐16, mean (SD) | |||||
| Intervention (n=86) | 64 (12) | 68 (11) | <0.0001 | 5 (10) | 0.77 |
| Control (n=45) | 63 (14) | 66 (12) | 0.01 | 6 (11) | |
CES‐D indicates Center for Epidemiological Studies Depression Scale; MoCA, Montreal Cognitive Assessment; and SIS‐16, stroke impact scale
Analyses adjusted for sex, diabetes mellitus, and body mass index.
Physical Assessment Outcomes at Baseline and After 3 Months in the Intervention and Control Groups
| Intervention Arm (Total n=131) | Baseline | 3‐Month Follow‐Up | Paired | Averaged Intraindividual Change |
|
|---|---|---|---|---|---|
| 6‐min walk test (m), mean (SD) | |||||
| Intervention (n=86) | 365 (155) | 415 (163) | <0.0001 | 51 (97) | 0.0.64 |
| Control (n=45) | 339 (159) | 341 (164) | 0.14 | 30 (97) | |
| Timed Up & Go (s), mean (SD) | |||||
| Intervention (n=86) | 19 (13) | 16 (12) | <0.0001 | −4 (6) | 0.42 |
| Control (n=45) | 23 (26) | 17 (13) | 0.21 | −2 (8) | |
| 15‐meter walk speed test (s), mean (SD) | |||||
| Intervention | 18 (16) | 15 (12) | 0.004 | −3 (11) | 0.10 |
| Control (n=45) | 18 (14) | 35 (83) | 0.5 | 11 (78) | |
| 30‐s Stand Chair Test (rep.), mean (SD) | |||||
| Intervention (n=86) | 9 (5) | 11 (5) | <0.0001 | 2 (4) | 0.24 |
| Control (n=45) | 9 (5) | 9 (4) | 0.32 | 0.5 (3) | |
| 1RM upper body (kg), mean (SD) | |||||
| Intervention (n=86) | 34 (21) | 42 (21) | <0.0001 | 10 (8) | 0.06 |
| Control (n=45) | 26 (15) | 29 (18) | 0.13 | 4 (10) | |
| 1RM lower body (kg), mean (SD) | |||||
| Intervention (n=86) | 41 (40) | 114 (47) | <0.0001 | 25 (29) | 0.55 |
| Control (n=45) | 72 (41) | 90 (44) | 0.02 | 15 (28) | |
| Handgrip affected arm (kg), mean (SD) | |||||
| Intervention (n=86) | 21 (13) | 23 (14) | 0.002 | 3 (7) | 0.50 |
| Control (n=45) | 18 (11) | 18 (9) | 0.32 | 1 (4) | |
1RM indicates 1 repetition maximum.
Analyses adjusted for sex, diabetes mellitus, and body mass index.